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Summary 
The development of CD4 + T  helper (Th) type 1 and 2 cells is essential for the eradication of 
pathogens, but can also be responsible for various pathological disorders.  Therefore, modula- 
tion  of Th  cell  differentiation  may have  clinical  utility  in  the  treatment  of human  diseases. 
Here, we show that interleukin  (IL)  12  and  IL-4 directly induce  human  neonatal  CD4 +  T 
cells,  activated via CD3  and  CD28,  to  differentiate  into  Thl  and  Th2  subsets.  In contrast, 
IL-13, which shares many biological activities with IL-4, failed to induce T  cell differentiation, 
consistent with the observation that human T  cells  do not express IL-13 receptors. Both the 
IL-12-induced Thl subset and the IL-4-induced Th2 subset produce large quantities of IL-10, 
confirming that human IL-10 is not a typical human Th2 cytokine. Interestingly, IL-4-driven 
Th2  cell differentiation was completely prevented by an IL-4 mutant protein  (IL-4.Y124D), 
indicating that this molecule acts as a strong IL-4 receptor antagonist. Analysis of single T  cells 
producing interferon y or IL-4 revealed that induction of Thl cell differentiation occurred rap- 
idly and required only 4 d of priming of the neonatal CD4 + T  cells in the presence of IL-12. 
The IL-12-induced Thl  cell phenotype was stable and was not significantly affected when re- 
peatedly stimulated in the presence of recombinant IL-4. In contrast, the differentiation of Th2 
cells occurred slowly and required not only 6 d of priming, but also additional restimulation of 
the primed CD4 + T  cells in the presence of IL-4. Moreover, IL-4-induced Th2 cell pheno- 
types were not stable and could rapidly be reverted into a population predominantly containing 
Th0 and Thl  cells,  after a single restimulation in the presence of IL-12. The observed differ- 
ences in stability of IL-12- and IL-4-induced human Thl  and Th2 subsets, respectively, may 
have implications for cytokine-based therapies of chronic disease. 
T 
he outcome of a protective immune response against a 
pathogenic threat depends to a great extent on the dif- 
ferentiation of specialized Th subsets secreting specific cy- 
tokines. Two subsets of CD4 + Th cells,  referred to as Thl 
and Th2,  have been identified,  initially in the mouse and 
later in the human  (1-5).  Murine  Thl  cells  produce  IL-2 
and IFN-% but no IL-4 and IL-5, and have been shown to 
play an important role in cell-mediated immune responses 
against  intracellular  pathogens.  Th2  cells  produce  IL-4, 
IL-5, and  IL-10, but  no  IFN-% and are involved in  hu- 
moral  immunity  and  allergic  responses.  A  subset  of Th 
ceils,  designated Th0  cells,  simultaneously secretes Thl  as 
well as Th2 cytokines (6-9). Th0 cells may represent a sta- 
ble and distinct population of differentiated Th cells  or an 
intermediate stage of Th cells in the process of differentiat- 
ing into Thl  or Th2 cells (10). 
Although cytokine production profiles of human CD4 + 
Thl and Th2 T  cell clones are reminiscent of those ofmu- 
rine Thl  or Th2 clones, the range of cytokines secreted is 
generally less  polarized.  Human Thl  and Th2  clones can 
still  produce  IL-4  or  IFN-%  respectively,  depending  on 
their mode of activation (3,  11).  In addition,  human Th2 
clones  are  able  to  produce  significant  amounts  of IFN-y 
when activated in the presence of IL-12 (12,  13)  or when 
stimulated with phorbol ester and calcium ionophore (11), 
demonstrating that the IFN-y gene is not permanently si- 
lent in these cells. 
It is clear from studies in the mouse, as well as in the hu- 
man, that the presence of cytokines at the onset of an im- 
mune response determines the development of a particular 
Th phenotype. Priming of naive cells in vitro in the pres- 
ence  of IL-4 results in  the  generation  of IL-4-producing 
Th2 effector cells (14-18). Furthermore, IL-4 has also been 
shown  to  induce  Th2  responses  in  vivo  (19,  20).  Con- 
versely, IL-12, produced by monocytes and dendritic cells, 
drives the differentiation of naive T cells toward IFN-~/-pro- 
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Volume 184  August 1996 473-483 ducing cells  (21-23)  and also  enhances the production of 
IFN-y by allergen-specific Th2 clones (12,  13). 
In view of the  important role  that  Th  subsets seem to 
play in the regulation of immune responses, it is important 
to  obtain information about  the  stability of the  Thl  and 
Th2 phenotypes. It has been shown that polarized IL-12- 
induced mouse Thl populations still responded to the Th2 
cell  differentiation-inducing effects  of rlL-4  in vitro  (24, 
25). In contrast, the phenotype of Th2 populations derived 
from  transgenic  mice  was  not  reversible  by  stimulation 
with rlL-12 (24), whereas stimulation of Leishmania major- 
specific Th2 cells in the presence ofrlFN-y and rlL-12 en- 
hanced the production of IFN-y, but was not able to  in- 
duce a  total  conversion of these  cells into Thl  cells  (25). 
The resistance of CD4 + murine Th2 cells to the effects of 
rlL-12 may to be due to an IL-12-signaling defect reflect- 
ing a downregulation oflL-12 receptors on these cells (26). 
In the human, it has been reported that purified protein 
derivative-specific T  cell clones that normally show a Thl- 
like cytokine production profile secreted high levels of IL-4, 
as  well as  IFN-',/, when they were  generated in the pres- 
ence of IL-4 in vitro (17).  Conversely, allergen-specific T 
cell  clones,  generated  in  the  presence  of IFN-or  IFN-y 
(17), or IL-12 (23), produced little IL-4 and high levels of 
IFN-y. Although the latter results show that antigen-spe- 
cific T  cells can be induced to produce certain cytokines in 
response to stimulation with recall antigens, little is known 
about the conditions responsible for the development and 
reversibility of committed Thl and Th2 populations. 
In the  present study, we  have studied the  effect  of the 
differentiation-inducing  cytokines IL-4 and IFN-y on the 
in vitro development of Thl  and Th2 subsets from naive 
human neonatal CD4 + T  cells. In addition, using flow cy- 
tometry  we  have  analyzed  the  production  of  IL-4  and 
IFN-~/at the single-cell level to determine the plasticity of 
polarized Thl and Th2 subsets. 
Materials  and Methods 
Human Neonatal CD4 + T Cells.  Human neonatal leukocytes 
were isolated from freshly collected,  heparinized, neonatal blood 
by density gradient centrifugation using Histopaque 1077 (Sigma 
Chemical Co., St. Louis, MO). Adherent cells were removed by 
incubation of the  cells  on a  plastic  petri  dish  (Falcon;  Becton 
Dickinson Labware,  Lincoln Park,  NJ)  for  1 h  at  37~  in the 
presence  of 6  txg/ml DNase  (Sigma  Chemical Co.).  Neonatal 
CD4 + T cells were purified from nonadherent lymphocytes using 
magnetic microspheres.  Briefly, nonadherent cells were incubated 
with  anti-CD4  mAb-coated  Dynabeads  (Dynal,  Great  Neck, 
NY) at a 10:1 bead to cell ratio for 1 h at 4~  with gently rotat- 
ing. CD4 + T  cells were isolated  from the bead/cell mixture by 
exposure  to a magnetic field using a magnetic particle concentra- 
tor  (Dynal),  according to  the  manufacturer's instructions. Cells 
were washed  five times  with PBS, supplemented with 2% FCS, 
and the bead/cell complexes were incubated with Dynal Detach- 
abead reagent for 1 h at room temperature with vigorous shaking. 
The detached  cells were collected  by applying a magnetic field, 
tbllowed by washing twice  with  PBS/2%  FCS.  The  purity of 
positively  selected  neonatal CD4 + T  cells, using this procedure, 
was typically >97%, as determined by flow cytometry. 
Mouse L  Cell Transfeetants.  Mouse  L  cells, transfected  with 
CD32 (FcyRII) (27), human CD58 (LFA-3), and human CD80 
(B7.1), were generated as described previously (28, 29) and were 
kind gifts from Drs. R. de Waal Malefyt and L.L. Lanier (DNAX 
Research Institute).  The expression of CD58 and CD80 on the L 
cell transfectants was monitored periodically by flow cytometry. 
mAbs and Reagents,  mAbs used for activation of T  cells were 
the  anti-CD3  mAb  SPV-T3b  (30) and  the  anti-CD28  mAb 
L293.1  (a kind gift of Dr. L. Lanier). mAbs used for intracellular 
cytokine staining were the anti-hlL-4 mAb 25D2  (31) and the 
anti-hlFN-y mAb B27  (32). Cytokines used  in this study  were 
rIL-2, rlL-13 (generously  provided by Drs.  G.  Zurawski and S. 
Menon, respectively, from the DNAX Research Institute),  rlL-4 
(Schering-Plough  Research Institute, Kennilworth, NJ), and rlL-12 
(purchased from R. & D Systems, Minneapolis, MN). The IL-4R. 
antagonist IL-4.Y124D (33) was a generous gift of Dr. G. Zurawski. 
Cells were cultured in DMEM/High, supplemented with 2 mM 
t-glutamine, 1 mM sodium pyruvate,  100 U/ml penicillin-strep- 
tomycin (JRH  Biosciences,  Lenexa,  KS), and  10%  FCS  (Sigma 
Chemical Co.). 
Culture Conditions.  L cell transfectants,  used in coculture ex- 
periments  were  detached  by  20-min  incubation at  37~  m 
EDTA  (Versene;  Flow  Laboratories,  McLean,  VA)  and  were 
washed twice in PBS (supplemented with 2% FCS), irradiated  at 
7,000 rad, and washed once in DMEM/10% FCS. 2 ￿  l0  s neo- 
natal CD4 + T cells were incubated with 2 ￿  1()  s irradiated L cell 
transfectants,  100  ng/ml of anti-CD3 mAb, and  100  U/ml of 
rlL-2 in the presence  or absence  of combinations of 10  ng/ml 
rlL-4, 0.5 ng/ml rIL-12, 200 U/in] rlL-13, or various concentra- 
tions of the IL-4P, antagonist IL-4.Y124D, in 24-well tissue cul- 
ture plates (Linbro,  Flow Laboratories) in a final volume of l  ml. 
Neonatal CD4 + T cells were cultured for 6 d, washed with fresh 
culture medium, and restimulated  under the same conditions for 
another 6  d  after which the production of cytokines was mea- 
sured, as described below. 
Restimulation qf Cells  for Analysis of Cytokine  Production by Cyto- 
kine-spec!'t~c Immunoassay.  Anti-CD3 mAb was  coated  overnight 
on tissue culture plates at a concentration of 10 Ixg/ml in PBS 
and plates were washed  twice with medium before the addition 
of the  cells. I(Y' cultured neonatal T  cells/ml were  stimulated 
with plastic-coated  anti-CD3 mAb and 1 Ixg/ml of soluble anti- 
CD28 n~b, in the presence  of 100 U/ml rlL-2. After  48  h of 
activation,  supernatants  were harvested,  spun a~ 250 g to remove 
remaining cells, aliquoted,  and stored  at  -80~  before  testing. 
Cytokine levels in the supernatants of activated neonatal CD4 + T 
cells were determined by cytokine-specific immuuoassays,  using 
antibodies specific for IL-4,  IL-5, IL-10,  IL-13,  and IFN-y, as 
described  previously (34). Sensitivity of the assay for IL-13 pro- 
duction was 100 pg/ml, whereas the sensitivity of all other assays 
was 50 pg/ln]. 
Restimulation qf Cells  for Analysis  ~f Intracellular Cytokine  Produc- 
tion by Flow Cytometry.  Intracellular cytokines were detected by 
flow cytometry using the method of Andersson et al.  (9), with 
modifications  (35-38).  Briefly,  10  ~'  neonatal CD4 +  T  cells/nil 
were stimulated  with plate-bound anti-CD3 mAb and  1 Ixg/ml 
of soluble anti-CD28 mAb in the presence  of 100 U/nil rlL-2. 
After 3 h of activation,  10 #xg/ml ofBrefeldin A (Sigma Chemical 
Co.) was added to the cultures and the cells were cultured for an 
additional 2 h. After a total of 5 h of activation, neonatal CD4 + T 
cells were washed  in PBS, fixed by incubation for 20 rain with 
2%  formaldehyde  (Sigma  Chemical  Co.),  washed  twice  with 
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mented with 2% FCS,  2 mM NAN3, and 0.5%  saponin;  Sigma 
Chemical Co.). All incubations were camed out at room temper- 
ature.  Permeabilized T cells were incubated with PE-labeled anti- 
hlL-4  mAb  and  FITC-labeled  anti-hlFN-y  mAb,  diluted  in 
PBS/FCS/NaN3/  saponin.  After 30 min of incubation at room 
temperature, cells were washed twice with the same buffer, resus- 
pended in PBS  (supplemented with 2% FCS and 2 mM NAN3), 
and analyzed using a FACScan  |  flow cytometer (Becton Dickin- 
son & Co., San Jose, CA). Data are displayed  as dot plots  of PE 
(x-axis) and FITC (y-axis) fluorescence (four decade log scales). 
Quadrant markers were positioned to include >98% of control Ig 
stained cells in the lower left quadrant.  Methods of flow cytome- 
try and data analysis were carried  out as described  by Lanier and 
Recktenwald (39). 
Results 
rlL-12 Drives  Th l  Development,  and rlL-4 but Not rlL-13 
Drives Th2 Development In  Vitro.  To determine  the effects 
of IL-4, IL-12, and IL-13 on the differentiation of naive T 
cells,  highly purified  neonatal  CD4 +,  CD45R.A +  T  cells 
were  repeatedly  activated  with  anti-CD3  mAb,  cross- 
linked on CD32 + mouse L cells,  expressing human CD58 
and CD80,  in the presence of these cytokines. All cultures 
contained  100 U/ml rlL-2 to ensure cell viability and pro- 
liferation.  At the  end  of each  of the  two  consecutive  6-d 
culture periods,  referred  to as first and second stimulation, 
respectively,  the  cells  were  activated  with  plate-bound 
anti-CD3  mAb and  soluble  anti-CD28  mAb in  the  pres- 
ence ofrlL-2, and the cytokine production profile was an- 
alyzed by immunoassay. As is shown in Table  1,  neonatal 
CD4 + T  cells stimulated twice in the presence ofrlL-4 dif- 
ferentiated  into  Th2  populations  that  produced  high 
amounts oflL-4, IL-5, and IL-13, upon subsequent activa- 
tion  with  plate-bound  anti-CD3  mAb  and  soluble  anti- 
CD28  mAb in the  presence  of rlL-2.  The  production  of 
IFN-y in these cultures was generally low (but not absent) 
and varied between donors.  In contrast, in the presence of 
rlL-12, neonatal CD4 + T  cells from seven out of seven do- 
nors  differentiated  into  Thl  cells,  secreting high  amounts 
oflFN-y. However, in three out of seven donors, neonatal 
CD4 + T  cells  cultured in the presence ofrlL-12 also pro- 
duced significant levels of IL-4 and  IL-13 after activation, 
whereas in the other four donors,  IL-4 and IL-13 produc- 
tion was below the level of detection.  The production  of 
IL-5, however, was never detectable,  suggesting that IL-12 
induced the differentiation of an IL-4- and IL-13-, but not 
IL-5- producing T  cell subset under these conditions. The 
Thl  and Th2 subsets generated in the presence of rlL-4 or 
rlL-12,  respectively,  both produced  high  levels  of IL-10, 
confirming  previous  results  indicating  that  IL-10  is  pro- 
duced  by both  human  Thl  and  Th2  cells  (40).  Further- 
more,  these  results  are  consistent  with  data  showing  that 
IL-12  synergizes  with  IL-2  to  induce  IL-10  production 
(41),  although  in  all  experiments,  rlL-4-driven  cultures 
tended  to  produce  higher  levels  of IL-10.  Activation  of 
neonatal CD4 + T  cells in the presence of a combination of 
rlL-4 and rlL-12 resulted in the generation of a population 
of T  cells  that  produced  relatively  high  amounts  of both 
Thl  and Th2 cytokines, including IL-4, IL-5, IL-10, IL-13, 
and IFN-y (Table  1). 
T  cells stimulated in the presence of  both rlL-4 and rlL-12 
produced higher levels of IL-4, IL-5, and IL-13 after acti- 
vation,  as  compared  with  T  cells  that  developed  in  the 
presence  of rlL-12  alone.  Levels  of IFN-y production  in 
these cultures, however, were comparable. Conversely, the 
levels of IL-4 production were reduced by ~30-50%, but a 
strong increase in IFN-y production was observed, as corn- 
Table  1.  Cytokine Production Profile of Th I and Th2 Populations, Generated  from Human Neonatal CD4  + T Cells 
Cytokine production (ng/106 cells) 
Cytokines added  IL-4  IL-5  IL-  10  IL-  13  IFN-y 
Control  0.1  (<0.1-0.7)  <0.1  (<0.1-0.12)  4.4  (1.6-6.4)  0.6  (<0.2-1.9)  0.2  (<0.1-1.3) 
(n= 7)  (n= 7)  (n =  6)  (n =3)  (n= 7) 
IL-4  2.5  (0.67-7.0)  1.7  (0.4-2.9)  68.8  (42.9->100)  9.3  (6.6-11.4)  0.2  (0.1-0.6) 
(n  =  7)  (n  =  7)  (n  =  6)  (n  =  3)  (n  =  7) 
IL-12  0.8  (<0.1-3.6)  0.1  (<0.1-0.2)  33.0  (19.3-53.0)  2.3  (<0.2-5.6)  3.9  (1.3->10.0) 
(n=7)  (n=7)  (n=6)  (n=3)  (n=7) 
IL-4 +  IL-12  1.8  (0.3-4.3)  0.9  (<0.1-1.7)  27.4  (4.0-59.0)  6.2  (1.2-10.8)  3.8  (1.22->10.0) 
(n  =  7)  (n  =  7)  (.  =  6)  (n  =  3)  (n  =  7) 
IL-13  0.l  (<0.1-0.1)  <0.1  (<0.1-0.1)  4.6  (1.8-7.5)  0.5  (<0.2-1.4)  0.3  (<0.1-1.4) 
(n=4)  (n= 4)  (n= 4)  (n= 3)  (n=4) 
Neonatal CD4 + T cells were stimulated twice, at 6-day intervals, with anti-CD3 mAb and L cell transfectants in the presence ofrlL-2 (Control), or 
in the presence ofrlL-2 and combinations ofrlL-4, rlL-12 or tiE-13, respectively. Cells were harvested and cytokine production levels were ana- 
lyzed by cytokine-specific immunoassay. Data are presented as average of"n" independent donors. Maximum and minimum cytokine titers for each 
group are included. Refer to Materials and Methods for conditions of culture and analysis for cytokine production. 
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lated in the presence of rlL-4 alone. Finally, in this culture 
system, rlL-13 added at concentrations as high as 200 U/ml 
was unable to induce the differentiation of neonatal CD4 + 
T  cells into mature effector T  cells, consistent with the ob- 
servation that T  cells do not express IL-13R. 
The IL-4R Mutant Protein IL-4. Y I 2 4D,  Specifically Inhibits 
IL-4-mediated  Th2 Differentiation.  Recendy,  we  described 
an IL-4 mutant protein in which the Tyr residue at position 
124 is replaced by an Asp (IL-4.Y124D)  (33). IL-4,Y124D 
binds with high  affinity to  the  IL-4R,  ot  chain without  re- 
ceptor activation. Since the  IL-4IL and the  IL-13R chain 
share the IL-41Lot chain that is required for signal transduc- 
tion, IL-4.Y124D  acts as an antagonist for both the IL-4P,, 
and IL-13R in vitro and in vivo (33, 42, 43). Here, we in- 
vestigated whether  the  mutant  IL-4 protein could inhibit 
IL-4-driven Th2 differentiation. As is shown in Fig. 1,  IL- 
4.Y124D,  added at a 20-fold excess over the concentration 
of rIL-4,  completely prevented  IL-4-induced  differentia- 
tion of IL-5- and  IL-13-producing cells. The  addition of 
lL-4.Y124D also inhibited the generation of IL-4-produc- 
ing  cells  in  a  dose-dependent  way.  Prevention  of IL-4- 
induced differentiation of neonatal cells into IL-4-produc- 
ing Th2  cells by IL-4.Y124D  was confirmed by Northern 
analysis.  No  IL-4  mRNA  could be  detected  in  neonatal 
CD4 + T  cells cultured in the presence of rlL-4 and a  20- 
fold excess of IL- 4.Y124D  (results not shown). 
IL-4 and IL-12 Induce  Neonatal  CD4 + T  Cells to Differen- 
tiate  into Polarized Subsets of Th  Cells.  It is not possible to 
determine,  using  cytokine  immunoassays,  whether  Thl 
and Th2 cytokines are produced by the same cell or differ- 
ent cells within a polyclonal population. Therefore, we an- 
alyzed IL-4- and IL-12-induced differentiation of neonatal 
CD4 + T  cells at the single-cell level, by measuring their in- 
tracellular production of IL-4 and IFN-y by flow cytome- 
try.  Neonatal  CD4 +  T  cells stimulated twice  with  cross- 
linked anti-CD3  mAb in the presence of exogenous rlL-4 
gave rise to  a  population of Th2  cells (12-20%)  that pro- 
duced only IL-4 and no IFN-~/ (Figs. 2 and 3). In addition, 
a  small proportion  (4-6%)  of IFN-~/-producing cells was 
reproducibly  detected  in  this  population,  indicating  that 
IL-4  IL-5  IL-13  6,1   ~  ~o 
1~  20 
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Figure  1.  Effect of the  IL-4 mutant  protein  IL-4.YI24D  on  IL-4- 
induced production of IL-4, IL-5, and lL-13 by differentiated neonatal 
CD4 + T cells. Neonatal CD4"- T cells were stimulated twice, at 6-d in- 
tervals, with anti-CD3  mAb and L cell transfectants, in the presence of 
rlL-2, rIL-4, and increasing concentrations of IL-4.Y124D. Cells were 
harvested and cytokine production levels were analyzed by cytokine-spe- 
cific immunoassay. (N.T.) Not tested. 
IL-4 induces the generation of a subset of IFN-~/-produc- 
ing  Thl  cells  that  appears  relatively late  after  activation 
(Fig, 3). The majority (70-80%)  of the cells did not appear 
to  be  committed  to  the  production  of IFN-y  or  IL-4. 
However, it is not possible to conclude whether these cells 
are truly uncommitted or whether  their cytokine produc- 
tion levels are below the sensitivity of the assay. These re- 
suits,  analyzed at  the  single-cell level, are  consistent with 
the  cytokine production levels measured by immunoassay 
(Table 1) and strongly suggest that the low levels of IFN-'y 
detected in rlL-4-primed cultures are produced by a subset 
of IFN-y-producing Thl  cells. 
In contrast,  >30%  of neonatal CD4 + T  cells stimulated 
repeatedly in the presence ofrlL-12 differentiated into Thl 
cells, producing high levels of IFN-'y but  no  IL-4,  How- 
ever, a  small fraction of neonatal CD4 +  T  cells stimulated 
in the presence ofrlL-12 produced IL-4 and IFN-y simul- 
taneously. This is consistent with the observation that rlL-12 
induced low levels of IL-4 protein at the population level 
(Table  1), and indicates that this IL-4 is derived from Th0 
cells. Stimulation of neonatal CD4+  T  cells in the presence 
of both rlL-4 and rlL-12 resulted in a  two-  to  three-fold 
reduction  in  IL-4--producing Th2  cells  and  a  strong  in- 
crease (6-10-fold) in IFN-y-producing Thl  cells, as com- 
pared with neonatal CD4 + T  cells, stimulated in the pres- 
ence of rlL-4 alone (Figs. 2 and 3). On the other hand, the 
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Figure  2.  lntracellular cytokine production  of Thl  and Th2 popula- 
tions. Neonatal CD4 + T  cells were stimulated twice, at 6-d intervals, 
with  anti-CD3  nLAb and L cell transfectants in  the  presence of rIL-2 
(Control), or in the presence ofrlL-2 and combinations  ofrlL-4 and rlL- 12, 
respectively.  After this culture period, cells  were harvested and the intvacel- 
lular production of IL-4 and IFN-y was analyzed  by flow cytometry. 
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Figure 3.  Kinetics of differen- 
tiation of Thl  and Th2 subpop- 
ulations. Neonatal CD4 + T  cells 
were  stimulated with  anti-CD3 
mAb  and L  cell  transfectants in 
the presence of rlL-2  (Control), 
or  in  the presence of rlL-2  and 
combinations of rlL-4 and rlL-12, 
respectively.  At 4  and  6  d  after 
the first and the second stimula- 
tion, the cells were harvested and 
the  intracellular  production  of 
IL-4 and IFN-"/was analyzed by 
flow cytometry. 
presence of rlL-4 failed to reduce the frequency of IL-12- 
induced IFN-'y-producing cells, but induced a small popu- 
lation of IL-4-producing Th2 cells (Figs. 2 and 3).  In addi- 
tion, considerable numbers (8-15%) of individual Th0 cells 
that simultaneously secreted IL-4 and  IFN-~ were gener- 
ated in these cultures. Control cultures, containing neona- 
tal CD4 + T  cells,  stimulated twice in the presence of rlL-2 
alone, failed to differentiate into IL-4- or IFN-~/-produc- 
ing Th0, Thl, or Th2 cells. No IL-4- or IFN-~/-producing 
cells could be detected in control T  cells that had not been 
activated by plate-bound anti-CD3 and soluble anti-CD28 
mAbs  (data  not  shown),  indicating  that  IL-4 and  IFN-~/ 
production detected in these populations reflected neosyn- 
thesis of these cytokines. Taken together,  the results indi- 
cate that IL-12 seems to be more potent in redirecting IL-4- 
driven Th2 differentiation of neonatal CD4 + T  cells,  than 
IL-4 in redirecting IL-12-mediated Thl cell differentiation. 
Kinetics  of Differentiation  of Neonatal  CD4 +  T  Cells,  In- 
duced by rlL-4 and rlL-12.  We analyzed the kinetics of in- 
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duction  of differentiation  of neonatal  CD4 +  T  cells  into 
Th0, Thl,  and Th2 cells,  after stimulation in the presence 
ofrlL-4 and/or rlL-12. After stimulation in the presence of 
rlL-2  alone,  a  subset  of IFN-~/-producing Thl  cells  ap- 
peared rapidly during the first 4 d of culture, but could no 
longer be detected at day 6  of stimulation  (Fig.  3).  In the 
presence of rlL-4, no IFN-~/-producing cells  were gener- 
ated,  indicating  that  rlL-4  inhibited  the  development  of 
these early-appearing IFN-~/-producing Thl cells. Interest- 
ingly, only very low numbers (2%) of IL-4-producing Th2 
cells could be detected after the cells had been restimulated 
in the presence ofrlL-4 for 6 d. The frequency oflL-4-pro- 
ducing cells,  however, increased dramatically to "~20% af- 
ter restimulation, suggesting that neonatal CD4 + T  cells re- 
quire at least two consecutive stimulations in the presence 
of IL-4 in  order to optimally differentiate into  Th2  cells. 
rlL-4 also induced the development of  a subset oflFN-'y-pro- 
ducing Thl cells, which appeared late, concomitantly with 
IL-4-producing cells  during  the  second  stimulation.  This subset of Thl  cells differs from the one appearing early in 
the  presence  of rIL-2,  since  the  generation  of the  latter 
population is suppressed by IL-4 (Fig. 3). 
In contrast to the slow development of IL-4-producing 
Th2  cells, high frequencies (60-70%)  of IFN-~/-producing 
Thl  cells were detected as early as 4  d  after stimulation in 
the presence ofrIL-12 (Fig. 3). However, after 6 d of culture, 
the proportion of IFN-y-producing Thl  cells stabilized at 
lower frequencies (30-40%).  The decrease in frequency of 
these cells paralleled the progressive loss of IFN-y-produc- 
ing cells, observed in the control cultures, which contained 
only rIL-2, suggesting that the high percentages of IFN-y- 
producing Thl  cells detected early in these cultures can be 
attributed to  the additive effects of rIL-2 and rlL-12. The 
presence  of rIL-4  in  rIL-12-containing  cultures  partially 
prevented  this  early  burst  of  IFN-y-producing  T  cells. 
However, during the second stimulation of neonatal CD4 + 
T  ceils in the presence ofrlL-4 and rIL-12, additive effects 
were  observed  on  the  frequencies  of  IFN-~/-producing 
Thl  cells, confirming the notion that rIL-4 enhanced  the 
late  differentiation  of a  subset  of IFN-y-producing cells, 
consistent  with  the  protein  data  shown  in  Table  1.  IL-4 
and IL-12 clearly synergized in inducing Th0 cell differen- 
tiation,  whereas  a  strong  reduction  in  the  generation  of 
Th2  single cells was  observed,  as compared with  cultures 
carried out in the presence of rlL-4 alone. Kinetics of dif- 
ferentiation of IL-4-, as well as IFN-~/-producing Th cells, 
induced by the  combination of rlL-4 and rlL-12  (Fig. 3), 
paralleled differentiation kinetics of these cells induced by 
each of the cytokines alone. The majority of IL-4-produc- 
ing Th cells detected among this population also produced 
IFN-'y and thus belonged to the Th0 subset. 
It is important to note that differences in differentiation 
kinetics of Thl  and Th2 cells were unlikely to be due to a 
difference in growth of neonatal CD4 + T  cells in response 
to rlL-4 and rlL-12, since similar cell numbers were recov- 
Table 2.  Growth Characteristics of Cultured Human Neonatal 
CD4  + T Cells 
Cell recovery (fold of initial population) 
First stimulation  Second stimulation 
Cytokine added  Day 0-+4  Day 0-46  Day 6-410  Day6-+12 
Control  6.9  3.8  0.8  1.9 
IL-4  6.4  17.8  3.0  3.2 
IL-12  6.5  13.3  1.7  3.0 
IL-4 +  IL-12  5.4  33.2  1.7  4.0 
Neonatal  CD4 + T  cells were stimulated twice, at 6-d intervals, with 
anti-CD3 mAb and L cell transfectants, in the presence of rlL-2 (Con- 
trol), or in the presence ofrlL-2 and combinations ofrlL-4 and rlL-12, 
respectively. At the indicated culture periods, cell recovery was deter- 
mined by trypan blue exclusion. 
ered during stimulation in the presence of these  cytokines 
(Table 2). 
Stability  of Th I  and Th2 Populations  Derived  from Neonatal 
CD4 + T  Cells.  The  use  of cytokines  to  manipulate  Th 
differentiation may have  clinical utility in the treatment of 
several human diseases. However, it is still unclear whether 
it is possible to  modulate  the  phenotype  of polarized hu- 
man Th populations. To address this question, we analyzed 
the  distribution  of  IL-4-  and  IFN-y-producing  cells 
among  differentiated Thl  and  Th2  populations that  were 
restimulated  in  the  presence  of rlL-4  or  rlL-12,  respec- 
tively. Restimulation  in  the  presence  of rlL-12  of a  Th2 
population that was generated by two consecutive stimula- 
tions  in  the  presence  of rlL-4  (Fig.  4  A)  resulted  in  the 
emergence  of  IFN-~/-producing  Thl  and  IFN-y-  and 
IL-4-producing Th0  cells and,  concomitantly, in a  strong 
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Figure 4.  Phenotype of Th2, but not of Thl populations is reversible 
after stimulation with  oppositely polarizing stimuli. Neonatal CI)4  + T 
cells were stimulated twice, at 6-d intervals, with anti-Cl)3 mAb and L 
cell transfectants  and rlL-2 in the presence of rib4 (A) or rlL-12 (D), re- 
spectively. After this culture period, the cells were harvested, washed, and 
restimulated under  identical conditions with  rlL-4 (B and  E)  or with 
rlL-12 (C and F). 6 d later, ceils were harvested and the intracetlular pro- 
duction of IL-4 and IFN-y was analyzed by flow cytometry. 
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ever,  the  same  Th2  cells,  restimulated  in  the  presence of 
rlL-4, retained their phenotype (Fig. 4/3). In contrast, Thl 
populations  derived  from  neonatal  CD4 §  T  cells  in  the 
presence ofrlL-12 (Fig.  4 D) and restimulated in the pres- 
ence of rlL-4 (Fig.  4 F) retained their Thl  phenotype and 
did not differ significantly from their counterparts that had 
been restimulated in  the presence  of rlL-12  alone  (Fig.  4 
E).  Furthermore,  Thl  populations  derived after only one 
stimulation  of neonatal  T  cells  in  the  presence  of rlL-12 
(Fig.  5 B) retained their predominant Thl phenotype even 
after two restimulations in the presence of rlL-4 (Fig.  5, E 
and I), suggesting that even early IL-12-induced Thl pop- 
ulations cannot be readily skewed toward a Th0/Th2 phe- 
notype in  the presence of rlL- 4.  Conversely, neonatal T 
cells initially stimulated in the presence of rlL-4 (Fig.  5 A) 
and then restimulated in the presence of rlL-12 differenti- 
ated into a T  cell population in which  Thl  and Th0 cells 
frequencies  were  enhanced  five- to  seven-  and  three-  to 
five-fold, respectively (Fig.  5 D). However, in spite of their 
apparent  Thl  phenotype  after  the  second  stimulation,  a 
third stimulation of this Thl/Th0  population in the pres- 
ence  of rlL-4  gave rise  to  a  Th2/Th0  phenotype  (Fig.  5 
H),  with  frequencies  of IL-4-producing cells  comparable 
with those in populations of neonatal CD4 § T  cells, stimu- 
lated three times in the presence of rlL-4 (Fig.  5  G). This 
result  suggests  that  priming in  the  presence  of rlL-4  was 
pivotal  for  the  subsequent  generation  of IL-4-producing 
Th2 cells from this population.  In contrast, the population 
that had been initially stimulated in the presence of rlL-12 
retained a Thl phenotype even after two consecutive stim- 
ulations in the presence of rlL-4 (Fig.  5 I), indicating that 
the  presence  of rlL-12  during  the  initial  stimulation  di- 
rectly induced  a  stable  differentiation  of Thl  cells.  How- 
ever,  both  the  proportion  of IFN-~/-producing cells  and 
the  intensity  of production  of this  cytokine  among  this 
population were significantly lower than the proportion of 
IFN-'y-producing Thl  cells  and  the  intensity  of produc- 
tion of IFN-~/detected among the control population that 
had  been  repeatedly stimulated  in  the presence  of rlL-12 
only (Fig. 5, F and J). The latter result indicates that despite 
the inability of IL-4 to reverse the phenotype of Thl pop- 
ulations, it may reduce the frequencies of Thl cells and the 
levels of IFN-y production per cell. 
Discussion 
We  report  here  that  repeated  stimulation  of neonatal 
CD4 § T  cells develops into Thl and Th2 subsets when the 
differentiation-inducing  cytokines,  IL-12 or IL-4,  respec- 
tively, are present during the priming of the cells,  but that 
differentiation  requirements  and  stability  with  respect  to 
cytokine  production  profiles  differ between  subsets.  Re- 
peated  stimulation  of neonatal  CD4 +  T  cells  with  anti- 
CD3 mAb, cross-linked on CD32 + mouse L cells express- 
ing CD80 and CD58 in the presence of rlL-4, resulted in 
the generation of a Th2 population, producing high levels 
Ell'St 
stimulation 
IL-4 
",2-  ~'~ 12.4 
~-.  :i~ 
~_ :i~..;... 
IL-12 
....  ￿9 "  61.5 lOa 
Second  Third 
stimulation  stimulation 
IL--4, 4  IL-4, 4, 4 
￿9  : ":.  % I ..s 
%  .~i%:~.  :'I~ I:+ I:  I  1 5. 
i~i  "  "  ;~!i'-.'. 
IL-4, 12  IL-4,  12, 4 
a/:.l..:.  ::  I 
~1~4.:"?:.:  '~31" I  ~1 '~L :::~: ~1;"  I 
IL-12, 4  IL-12, 4, 4 
"-II   "-lz-I  "q'  I 
 ti!::t 
1I.-12, 12  1I.-12, 12,  12 
%  :'  F 
/ 
IL-4  ,~,  ,~ J ~. 
Figure 5.  Plasticity of Thl and Th2 populations after alternating stimu- 
lations with oppositely polarizing stimuli. Neonatal CD4 + T  cells  were 
stimulated for 6 d, with anti-CD3 mAb, L cell transfectants, and rIL-2 in 
the presence of rIL-4  (A) or rIL-12  (B), respectively, rIL-4--primed cells 
were restimulated in the presence of rIL-4 (C)  or rIL-12 (D)  during the 
second stimulation, and in the presence ofrIL-4 during the third stimula- 
tion (G and H). rIL-12-primed cells were restimulated, in the presence of 
rIL-4 (E and 1) or rIL-12 (F and  J), during the second and the third stim- 
ulation. 6 d after the third stimulation, the cells were harvested and the in- 
tracellular production of IL-4 and IFN-",/was analyzed by flow cytometry. 
of IL-4, IL-5, IL-10, and IL-13, but low levels of IFN-y. 
Analysis of cytokine production at the single-cell level re- 
vealed  that  optimal  differentiation  of neonatal  CD4 +  T 
cells  into  IL-4-producing  Th2  cells  occurs  relatively 
slowly, since this process requires both priming and restim- 
ulation in the presence of IL-4. The slow kinetics of Th2 
cell  differentiation  was  not  due  to  the  initial  presence  of 
IFN-% since no significant levels of this cytokine could be 
detected  at either the protein level,  or the  RNA  level in 
the initial population of neonatal CD4 + T  cells, which is in 
keeping with reports in the literature  (44,  45).  Moreover, 
stimulation  of neonatal  CD4 +  T  cells  in  the  presence  of 
IL-4 and a neutralizing antibody against IFN-~/did not en- 
hance  IL-4 production  after the first stimulation  (data not 
shown), suggesting that blocking of IFN-~/does not accel- 
erate Th2 differentiation. 
479  Sornasse  et al. It has been reported that stimulation  of murine  CD4 +, 
CD45RA +  naive  T  cells  via  CD86  favors  differentiation 
into Th2 cells  (46,  47).  Therefore, it could be argued that 
the  failure  of rlL-4-primed  cells  to  produce  IL-4 after a 
single stimulation is due to the lack of CD86 expression on 
the L cell transfectants. However, Lanier et al. (48) have re- 
ported that stimulation of human peripheral blood T  cells 
with CD86-expressing L  cell transfectants induced  similar 
levels of Thl- and Th2-type cytokines. In addition, no dif- 
ferences in cytokine production profiles could be detected 
between CD45RA + or CD45RA-  T  cells that were stim- 
ulated  with  transfectants,  expressing  comparable levels  of 
CD80  or  CD86  (49).  Finally,  stimulation  of  neonatal 
CD4 + T  cells with cross-linked anti-CD3 and cytokines in 
our culture system yielded similar cytokine production pat- 
terns,  irrespective  of whether  the  L  cells  had  been trans- 
fected with  CD80  or CD86  (Sornasse,  T.,  and  H.  Yssel, 
unpublished results). 
The  data  reported  here  are  consistent  with  results  re- 
ported  previously,  demonstrating  that  differentiation  of 
neonatal T  cells into effector T  cells with a Th2 phenotype 
requires priming in the presence of IL-4 (14-16,  18,  50). 
The differentiation  of neonatal  CD4 +  T  cells  into  IL-4-, 
IL-5-, and IL-13-producing cells was completely inhibited 
by the  IL-4 mutant protein  IL-4.Y124D,  which  acts  as a 
potent IL-4R and IL-13R. antagonist, underscoring the ef- 
ficiency of this polypeptide. These results furthermore indi- 
cate that the induction of IL-4, IL-5, and IL-13 production 
depends  on  the  presence  of IL-4.  Since  allergy is  a  Th2 
cell-mediated disease,  the inhibitory effects, together with 
the  observation  that  IL-4.Y124D  blocks both  IL-4- and 
IL-13-induced IgE synthesis in vitro (42) and ongoing hu- 
man IgE synthesis in SCID-hu mice (43),  suggest that this 
IL-4 mutant protein may have clinical utility in the  treat- 
ment of allergic diseases. 
Since  IL-4 is species specific and therefore does not act 
on mouse L  cells,  it can be concluded  that its capacity to 
induce  Th2  differentiation  is  due  to  a  direct  effect on  T 
cells.  In contrast,  IL-13, which shares many biological ac- 
tivities with IL-4, was not effective in this culture system, 
which  is compatible with the observation that IL-13 does 
not act on T  cells,  due to the absence of an IL-13R-bind- 
ing protein on these cells  (33,  51). Although IL-13 cannot 
directly induce Th2 differentiation by direct action on the 
T  cells, it is possible that it may indirectly enhance the gen- 
eration of Th2 responses through its capacity to downregu- 
late the monocyte- and possibly dendritic cell-derived pro- 
duction  of  IFN-ci  and  IL-12  (52),  both  of which  are 
cytokines capable of inducing Thl differentiation (22,  23). 
The low levels of IFN-',/protein detected in cultures of 
neonatal CD4 + T  cells stimulated in the presence of rlL-4 
were produced by subsets of Thl  cells and,  to a lesser ex- 
tent,  by Th0  cells  that  appear late,  at about 4  d  after the 
second stimulation  (i.e.,  10 d  after onset of the culture) in 
the presence of rlL-4. These results suggest that IL-4 under 
these  conditions  can  induce  the  late  differentiation  of a 
subset  of Thl  cells.  On  the  other hand,  it cannot be ex- 
cluded that the late appearance of these IFN-~-producing 
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cells reflects IL-4-mediated outgrowth of a small subpopu- 
lation of Thl  cells  that was already present in the cultures 
of neonatal CD4 + T  cells before the priming of these cells 
with  anti-CD3  mAb.  However,  this  late-appearing  Thl 
subset  seems  to  be  different  from  the  IFN-~/-producing 
Thl population, which is induced rapidly and transiently in 
the presence of lL-12 alone, since the differentiation of the 
early  Thl  population  is,  unlike  the  late-appearing  Thl 
population, suppressed by IL-4. 
IL-12-induced differentiation of neonatal CD4 + T  cells 
into Thl  cells occurred rapidly, and priming of the cells in 
the presence of rlL-12 was sufficient to induce the genera- 
tion of high frequencies of IFN-~/-producing cells after 4 d 
of culture. Interestingly, in about half of the donors, signif- 
icant levels oflL-4 and IL-13 protein, but no IL-5 protein, 
could  be  detected  in  culture  supernatants  of  neonatal 
CD4 +  T  cells  that had been  repeatedly stimulated in  the 
presence  of rlL-12.  The  capacity of IL-12 to  induce  the 
production of IL-4 by CD4 § neonatal T  cells has been re- 
ported  before  (53).  However,  here  we  show  that  the 
IL-12-mediated production of IL-4 is derived from a pop- 
ulation of Th0 cells that also produces IFN-~ and not from 
Th2 cells,  since no Th2 cell differentiation of CD4 § neo- 
natal T  cells was observed in the presence ofrlL-12. 
Repetitive stimulation of neonatal CD4 + T  cells  in the 
presence of both rlL-4 and rlL-12 resulted in the genera- 
tion of a population of T  cells that produced high levels of 
IFN-y and levels oflL-4, IL-5, IL-10, and IL-13 that were 
about twofold reduced,  as compared with the production 
of these cytokines by neonatal CD4 § T  cells differentiated 
in  the  presence  of rlL-4 alone.  Analysis of cytokine  pro- 
duction at the single-cell level indicated that IL-12 induced 
a reduction in Th2 differentiation, whereas the percentage 
of  IL-4-producing  Th0  cells  was  increased,  which  ac- 
counted  for  comparable  percentages  of  IL-4-producing 
cells  under both conditions.  However, levels of IL-4 pro- 
tein  produced by T  cells  differentiated in the  presence of 
rlL-4 and rlL-12 were consistently lower than those gener- 
ated in rlL-4 alone; this probably implies that IL-4 produc- 
tion by Th0  cells  on a per cell basis  is most likely lower 
than that by single IL-4-producing Th2 cells.  The induc- 
tion of IL-4 production in the Th0 population,  generated 
in the presence ofrlL-4 and rlL-12, also required repetitive 
stimulation, suggesting that the requirements for induction 
of IL-4 production  by Th0  and  Th2  T  cells  are  similar. 
Furthermore,  these  data support the  notion that Th0  cells 
might be considered as a fully differentiated subpopulation 
of T  cells.  In addition,  these results support recently pub- 
lished data by Kelso et al.  (54)  which  suggest that the in- 
duction  of IL-4  and  IFN-y production  is  independently 
regulated. 
Interestingly, Th2 populations derived after two stimula- 
tions in the presence of rlL-4 are not stable, since a single 
restimulation in the presence ofrlL-12 gave rise to a popu- 
lation of Th0 and Thl cells, producing high levels oflFN-% 
in which IL-4-producing Th2 cells could no longer be de- 
tected.  These  results  are  in  keeping with  the  observation 
that  rIL-12  can rapidly induce  high  levels of IFN-'y pro- 
Stability of In Vitro-differentiated CD4  § Human Thl and Th2 Subsets duction  by  established  allergen-specific  Th2  clones  (12, 
13). In addition,  stimulation of allergen-specific Th2 clones 
with phorbol ester and calcium ionophore  (11)  via a path- 
way circumventing  triggering of the TCR/CD3  complex, 
or  with  anti-signaling  lymphocytic  activation  molecule 
mAb (55),  respectively, was found to induce high levels of 
IFN-~/ production,  indicating  that  the  IFN-'y gene  is not 
silent and can be upregulated in differentiated Th2 cells. It is 
presently not  clear whether  the rlL-12-induced  increase  in 
the frequency of Thl  cells in cultures that had been primed 
and restimulated in the presence ofrlL-4 reflects a complete 
conversion of IL-4-producing cells into Thl  cells or the dif- 
ferentiation  of naive neonatal  CD4 +  T  cells still  present  in 
these  populations,  which  are  not  committed  to  IL-4  or 
IFN-',/production  (Figs. 3-5). Alternatively, we cannot ex- 
clude the possibility that these cells produce  IL-4 or IFN-~/ 
at levels that are below the sensitivity of the assay. 
In contrast to the unstable cytokine production profile of 
Th2  populations  generated  in  the  presence  of rIL-4,  the 
cytokine production profile of Thl  neonatal  CD4 + T  cells 
is stable; repetitive stimulation of these cells in the presence 
of rIL-4 did not result in the induction  of single IL-4-pro- 
ducing Th2 cells. Importantly, however, among the popu- 
lation of Th0 cells generated by priming of neonatal CD4 + 
cells in  rIL-4 and  subsequent  stimulation  in rIL-12,  single 
IL-4-producing  cells  could  still  be  induced  after an  addi- 
tional stimulation  in  the presence  of rIL-4.  The induction 
of T  cells  that  produce  IL-4  and  no  IFN-~/  under  these 
conditions  occurred  despite  the  fact  that  restimulation  of 
rIL-4-primed cells in the presence ofrIL-12 clearly favored 
the  differentiation  of IFN-~/-producing  Thl  cells  and  in- 
hibited  the  differentiation  of IL-4-producing  Th2  cells. 
These  results  underscore  the  plasticity  of IL-4-primed  T 
cell populations,  but,  most importantly,  they indicate  that 
initial priming with IL-4 is pivotal for efficient Th2  differ- 
entiation. 
Unlike the ability of human neonatal CD4 + Th2 cells to 
alter their cytokine phenotype,  mouse Th2  cells appear to 
be stable in their cytokine production  profile early in their 
differentiation  and  either cannot  (24)  or can only partially 
(25)  be  induced  to  the  opposite  phenotype  by repetitive 
stimulation in the presence oflL-12 in vitro. The resistance 
of CD4 + murine  Th2  cells to the Thl  cell differentiation- 
inducing  effects of IL-12 may be due  to a downregulation 
of IL-12R,  resulting  in  an  IL-12-signaling  defect in  these 
cells (26). On the other hand, mouse Thl  cells still respond 
to the  Th2  cell differentiation-inducing  effects of rlL-4 in 
vitro  (24,  25),  whereas  human  Thl  cells seem to  be irre- 
versible  in  their  cytokine  production  profile.  The  differ- 
ences  in  stability  between  mouse  and  human  Th  subset 
may be due  to the  different in vitro conditions  and to the 
frequency of stimulation  of Th subsets with differentiation- 
inducing cytokines. In support of this is the recent study by 
Murphy  et al.  (56)  in which  it was reported  that cytokine 
production  profiles  of both  mouse  Thl  and  Th2  popula- 
tions are irreversible in vitro when these cells have been re- 
petitively stimulated in the presence ofrlL-12  or rlL-4, re- 
spectively. It has to be noted, however, that IL-12 was able 
to reverse an  established  lethal  Th2  response  after chronic 
infection  with  Leishmania  major into  a  healing  Thl  re- 
sponse,  when  given simultaneously  with  an antileishmani- 
cidal drug (57), indicating that under certain conditions po- 
larized  murine  Th2  responses  still  can  be  modulated  in 
vivo.  The  ability  to  alter  the  Th  phenotype  of human  T 
cells  by cytokine  exposure  may similarly be beneficial  for 
treatment of certain human diseases. 
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